Eslo-Met-5 Tablet is a combination antihypertensive medication containing Amlodipine 5 mg and Metoprolol Succinate 25 mg, indicated for the management of hypertension and angina pectoris. Amlodipine, a calcium channel blocker, exerts its effect by inhibiting calcium ion influx into vascular smooth muscle and cardiac muscle, resulting in vasodilation and reduced peripheral vascular resistance, thereby lowering blood pressure. Metoprolol Succinate, a selective beta-1 adrenergic receptor blocker, decreases heart rate, myocardial contractility, and cardiac output, contributing to blood pressure reduction and decreased myocardial oxygen demand. The synergistic action of these agents provides effective blood pressure control and symptomatic relief in angina. Eslo-Met-5 is typically prescribed when monotherapy is insufficient or when dual therapy offers superior cardiovascular protection. It should be used under medical supervision, with dosage adjustments based on patient response and tolerability. Caution is advised in patients with bradycardia, heart block, or severe hepatic impairment. Common adverse effects may include dizziness, fatigue, hypotension, and peripheral edema. Regular monitoring of blood pressure, heart rate, and renal function is recommended during therapy. Eslo-Met-5 Tablet offers a convenient once-daily dosing regimen to enhance patient compliance in managing cardiovascular conditions.